Study backs ultrasound at 6-month intervals for hepatocellular carcinoma screening

09/21/2013 | Healio (free registration)

A new meta-analysis finds that ultrasound performed every six months is reliable and cost-effective for hepatocellular carcinoma screening in cirrhotic patients. The study involved information from 12 studies in eight countries and was presented at the International Liver Cancer Association Annual Conference.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ